Larimar Therapeutics LRMR
NASDAQ LRMR
$2.73 +0.04 (+1.49%)
At close: Nov 11, 2026 · 4:00 PM EST

Larimar Therapeutics (LRMR) Other Operating Expenses (2019 - 2020)

Updated

Larimar Therapeutics' Other Operating Expenses was -$10,000 in Q1 2020.

Analysis

Larimar Therapeutics (LRMR) Other Operating Expenses (2019 - 2020) Analysis & Trends

For FY2019, Other Operating Expenses at Larimar Therapeutics came in at -$5.55 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Larimar Therapeutics 279.45 Mn -389.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 -10,000.00
Dec 31, 2019 -411,000.00
Sep 30, 2019 -4.02 Mn
API Access

Larimar Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=LRMR&period=max&api_key=YOUR_API_KEY